Follow The Filings

BTMD Biote Corp.

Health Care CLASS A COM Equity among managers we track

BTMD (Biote Corp.) 13F ownership among featured managers we track. Figures are as-filed 13F, not free float.

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by BTMD's executives, directors and 10% owners, from their Form 4s · last 12 months

All BTMD insider trades →
  • $202K bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Marc D Beer Chair
    Buy
    $202K 131,950 shares at $1.53 +122% to stake
    Traded Aug 10–11 Filed Aug 12

Also filed in the last 12 months, not counted as buying or selling: 1 option exercise.

SEC filings

Recent issuer filings from EDGAR · 20 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
10-Q
8-K 2.02,9.01
8-K/A 5.02
8-K 5.02,7.01,9.01
8-K 5.07
10-Q
8-K 2.02,9.01
8-K 7.01,9.01
DEFA14A
10-K
8-K 2.02,9.01
8-K 8.01
10-Q
8-K 2.02,9.01
10-Q
8-K 2.02,9.01
8-K 5.02,7.01,9.01
8-K 5.02
8-K 5.07
10-Q

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $185.36M $197.19M $192.22M
Net income $3.32M $3.16M $27.04M
Net margin * 1.8% 1.6% 14.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $122.34M $68.13M $54.67M
Total non-current assets * $32.95M $54.24M $52.94M
Total assets $155.3M $122.37M $107.61M
Total current liabilities $22.22M $51.51M $44.99M
Total non-current liabilities * $169.63M $173.06M $113.02M
Total equity -$29.4M -$105.93M -$58.54M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $26.88M $45.24M $35.19M
Cash from investing -$2.71M -$18.8M -$6.86M
Cash from financing -$14.38M -$76.08M -$43.56M
Net change in cash $9.77M -$49.66M -$15.22M

Ownership over time

filing count by report period · click a bar for that quarter’s holders